vs

Side-by-side financial comparison of Emerson Electric (EMR) and Ralph Lauren Corporation (RL). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $2.4B, roughly 1.8× Ralph Lauren Corporation). Ralph Lauren Corporation runs the higher net margin — 15.0% vs 13.9%, a 1.1% gap on every dollar of revenue. On growth, Ralph Lauren Corporation posted the faster year-over-year revenue change (12.2% vs 4.1%). Ralph Lauren Corporation produced more free cash flow last quarter ($704.0M vs $602.0M). Over the past eight quarters, Ralph Lauren Corporation's revenue compounded faster (23.9% CAGR vs -0.3%).

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

Ralph Lauren is an American fashion designer, philanthropist, and billionaire businessman, best known for founding the brand Ralph Lauren, a global multibillion-dollar enterprise. He stepped down as CEO of the company in September 2015 but remains executive chairman and chief creative officer. As of May 2025, his net worth is estimated at US$11.9 billion.

EMR vs RL — Head-to-Head

Bigger by revenue
EMR
EMR
1.8× larger
EMR
$4.3B
$2.4B
RL
Growing faster (revenue YoY)
RL
RL
+8.2% gap
RL
12.2%
4.1%
EMR
Higher net margin
RL
RL
1.1% more per $
RL
15.0%
13.9%
EMR
More free cash flow
RL
RL
$102.0M more FCF
RL
$704.0M
$602.0M
EMR
Faster 2-yr revenue CAGR
RL
RL
Annualised
RL
23.9%
-0.3%
EMR

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
EMR
EMR
RL
RL
Revenue
$4.3B
$2.4B
Net Profit
$605.0M
$361.6M
Gross Margin
53.2%
69.9%
Operating Margin
17.8%
19.6%
Net Margin
13.9%
15.0%
Revenue YoY
4.1%
12.2%
Net Profit YoY
3.4%
21.6%
EPS (diluted)
$1.07
$5.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMR
EMR
RL
RL
Q4 25
$4.3B
$2.4B
Q3 25
$4.9B
$2.0B
Q2 25
$4.6B
$1.7B
Q1 25
$4.4B
$1.7B
Q4 24
$4.2B
$2.1B
Q3 24
$4.6B
$1.7B
Q2 24
$4.4B
$1.5B
Q1 24
$4.4B
$1.6B
Net Profit
EMR
EMR
RL
RL
Q4 25
$605.0M
$361.6M
Q3 25
$637.0M
$207.5M
Q2 25
$586.0M
$220.4M
Q1 25
$485.0M
$129.0M
Q4 24
$585.0M
$297.4M
Q3 24
$996.0M
$147.9M
Q2 24
$329.0M
$168.6M
Q1 24
$501.0M
$90.7M
Gross Margin
EMR
EMR
RL
RL
Q4 25
53.2%
69.9%
Q3 25
51.9%
68.0%
Q2 25
52.6%
72.3%
Q1 25
53.5%
68.7%
Q4 24
53.5%
68.4%
Q3 24
51.3%
67.0%
Q2 24
52.8%
70.5%
Q1 24
52.2%
66.6%
Operating Margin
EMR
EMR
RL
RL
Q4 25
17.8%
19.6%
Q3 25
16.4%
12.2%
Q2 25
16.1%
15.9%
Q1 25
14.2%
9.1%
Q4 24
18.6%
18.2%
Q3 24
14.7%
10.4%
Q2 24
10.4%
13.8%
Q1 24
16.2%
6.9%
Net Margin
EMR
EMR
RL
RL
Q4 25
13.9%
15.0%
Q3 25
13.1%
10.3%
Q2 25
12.9%
12.8%
Q1 25
10.9%
7.6%
Q4 24
14.0%
13.9%
Q3 24
21.6%
8.6%
Q2 24
7.5%
11.1%
Q1 24
11.4%
5.8%
EPS (diluted)
EMR
EMR
RL
RL
Q4 25
$1.07
$5.82
Q3 25
$1.12
$3.32
Q2 25
$1.04
$3.52
Q1 25
$0.86
$2.03
Q4 24
$1.02
$4.66
Q3 24
$1.74
$2.31
Q2 24
$0.57
$2.61
Q1 24
$0.87
$1.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMR
EMR
RL
RL
Cash + ST InvestmentsLiquidity on hand
$2.3B
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$20.3B
$2.9B
Total Assets
$41.9B
$7.8B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMR
EMR
RL
RL
Q4 25
$2.3B
Q3 25
$1.6B
Q2 25
$2.3B
Q1 25
$2.1B
Q4 24
$2.1B
Q3 24
$1.7B
Q2 24
$1.8B
Q1 24
$1.8B
Total Debt
EMR
EMR
RL
RL
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Q1 24
$7.6B
Stockholders' Equity
EMR
EMR
RL
RL
Q4 25
$20.3B
$2.9B
Q3 25
$20.3B
$2.6B
Q2 25
$19.9B
$2.5B
Q1 25
$19.2B
$2.6B
Q4 24
$20.5B
$2.5B
Q3 24
$21.6B
$2.4B
Q2 24
$20.8B
$2.4B
Q1 24
$20.9B
$2.5B
Total Assets
EMR
EMR
RL
RL
Q4 25
$41.9B
$7.8B
Q3 25
$42.0B
$7.3B
Q2 25
$42.5B
$7.8B
Q1 25
$42.0B
$7.0B
Q4 24
$42.6B
$7.1B
Q3 24
$44.2B
$6.8B
Q2 24
$45.6B
$6.6B
Q1 24
$46.4B
$6.6B
Debt / Equity
EMR
EMR
RL
RL
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMR
EMR
RL
RL
Operating Cash FlowLast quarter
$699.0M
$779.6M
Free Cash FlowOCF − Capex
$602.0M
$704.0M
FCF MarginFCF / Revenue
13.9%
29.3%
Capex IntensityCapex / Revenue
2.2%
3.1%
Cash ConversionOCF / Net Profit
1.16×
2.16×
TTM Free Cash FlowTrailing 4 quarters
$4.4B
$694.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMR
EMR
RL
RL
Q4 25
$699.0M
$779.6M
Q3 25
$3.1B
$53.2M
Q2 25
$1.1B
$176.1M
Q1 25
$241.0M
$122.2M
Q4 24
$777.0M
$738.4M
Q3 24
$3.3B
$97.2M
Q2 24
$1.1B
$277.3M
Q1 24
$743.0M
Free Cash Flow
EMR
EMR
RL
RL
Q4 25
$602.0M
$704.0M
Q3 25
$2.7B
$-40.6M
Q2 25
$977.0M
$-11.2M
Q1 25
$154.0M
$42.3M
Q4 24
$694.0M
$677.2M
Q3 24
$2.9B
$55.5M
Q2 24
$998.0M
$243.9M
Q1 24
$661.0M
FCF Margin
EMR
EMR
RL
RL
Q4 25
13.9%
29.3%
Q3 25
54.9%
-2.0%
Q2 25
21.5%
-0.7%
Q1 25
3.5%
2.5%
Q4 24
16.6%
31.6%
Q3 24
63.1%
3.2%
Q2 24
22.8%
16.1%
Q1 24
15.1%
Capex Intensity
EMR
EMR
RL
RL
Q4 25
2.2%
3.1%
Q3 25
8.9%
4.7%
Q2 25
2.0%
10.9%
Q1 25
2.0%
4.7%
Q4 24
2.0%
2.9%
Q3 24
9.1%
2.4%
Q2 24
2.1%
2.2%
Q1 24
1.9%
Cash Conversion
EMR
EMR
RL
RL
Q4 25
1.16×
2.16×
Q3 25
4.86×
0.26×
Q2 25
1.83×
0.80×
Q1 25
0.50×
0.95×
Q4 24
1.33×
2.48×
Q3 24
3.35×
0.66×
Q2 24
3.31×
1.64×
Q1 24
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

RL
RL

Segment breakdown not available.

Related Comparisons